Your browser doesn't support javascript.
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing.
Bai, Han; Ma, Junpeng; Mao, Weikang; Zhang, Xuan; Nie, Yijun; Hao, Jingcan; Wang, Xiaorui; Qin, Hongyu; Zeng, Qiqi; Hu, Fang; Qi, Xin; Chen, Xiaobei; Li, Dong; Zhang, Binghong; Shi, Bingyin; Zhang, Chengsheng.
  • Bai H; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Ma J; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Mao W; LC-BIO TECHNOLOGIES (HANGZHOU) CO., LTD., Hanghzhou 310000, China.
  • Zhang X; Center for Molecular Diagnosis and Precision Medicine, The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006, China.
  • Nie Y; Center for Molecular Diagnosis and Precision Medicine, The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zhengjie, Nanchang 330006, China.
  • Hao J; Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China.
  • Wang X; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Qin H; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Zeng Q; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Hu F; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Qi X; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Chen X; Department of Infectious Diseases, The Renmin Hospital of Wuhan University, East campus, Gaoxin 6th Road, East Lake New Technology Development Zone, Wuhan 430040, China.
  • Li D; Department of Clinical Laboratory, The Renmin Hospital of Wuhan University, East campus, Gaoxin 6th Road, East Lake New Technology Development Zone, Wuhan 430040, China.
  • Zhang B; The Renmin Hospital of Wuhan University, East campus, Gaoxin 6th Road, East Lake New Technology Development Zone, Wuhan 430040, China.
  • Shi B; Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China. Electronic address: shibingy@126.com.
  • Zhang C; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China;
Blood Cells Mol Dis ; 97: 102678, 2022 11.
Article in English | MEDLINE | ID: covidwho-1944311
ABSTRACT
The T cell-mediated immune responses associated with asymptomatic infection (AS) of SARS-CoV-2 remain largely unknown. The diversity of T-cell receptor (TCR) repertoire is essential for generating effective immunity against viral infections in T cell response. Here, we performed the single-cell TCR sequencing of the PBMC samples from five AS subjects, 33 symptomatic COVID-19 patients and eleven healthy controls to investigate the size and the diversity of TCR repertoire. We subsequently analyzed the TCR repertoire diversity, the V and J gene segment deference, and the dominant combination of αß VJ gene pairing among these three study groups. Notably, we revealed significant TCR preference in the AS group, including the skewed usage of TRAV1-2-J33-TRBV6-4-J2-2 and TRAV1-2-J33-TRBV6-1-J2-3. Our findings may shed new light on understanding the immunopathogenesis of COVID-19 and help identify optimal TCRs for development of novel therapeutic strategies against SARS-CoV-2 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: Blood Cells Mol Dis Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: J.bcmd.2022.102678

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Journal: Blood Cells Mol Dis Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: J.bcmd.2022.102678